Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13)

Annals of Hematology

Volumn 81, Issue 8, 2002, Pages 430-435

  Bohm M ^a   Vigh, T ^a   Scharrer, I ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

ADAMTS13; Ristocetin cofactor activity; Thrombotic thrombocytopenic purpura; von Willebrand factor cleaving protease

Indexed keywords

BARIUM CHLORIDE; CORTICOSTEROID; METALLOPROTEINASE; POLYMER; RISTOCETIN; TROMETAMOL; UNCLASSIFIED DRUG; UREA; VINCRISTINE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACCURACY; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC LINKAGE; HEMOLYTIC ANEMIA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; METHODOLOGY; MOLECULAR WEIGHT; PEDIGREE; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; REMISSION; REPRODUCIBILITY; STATISTICAL ANALYSIS; TECHNIQUE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

BIOLOGICAL MARKERS; CALIBRATION; HEMOLYSIS; HUMANS; KINETICS; METALLOENDOPEPTIDASES; PLATELET COUNT; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 0036939561     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0502-3     Document Type: Article

References (35)

1. Allford SL, Harrison P, Lawrie AS, Liesner R, Mackie IJ, Machin SJ (2000) Von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura. Br J Haematol 111:1215-1222
2. Aronson DL, Krizek DM, Rick ME (2001) A rapid assay for the vWF protease. Thromb Haemost 85:184-185
3. Barbot J, Costa E, Guerra M, Barreirinho MS, Isvarlal P, Robles R, Gerritsen HE, Lämmle B, Furlan M (2001) Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Wille-brand factor-cleaving protease. Br J Haematol 113:649-651
4. Bianchi V, Zeerleder S, Kessler P, Robles R, Wuillemin W, Alberio L, Lämmle B (2002) vWF-cleaving protease in severe sepsis and septic shock (abstract 22). Ann Hematol 81 [Suppl]
5. Bukh A, Ingerslev J, Stenbjerg S, Hundahl Møoller NP (1986) The multimeric structure of plasma FVIII:Ag studied by electroelution and immunoperoxidase detection. Thromb Res 43:579-584
6. Chemnitz J, Draube A, Schulz A, Scheid C, Fuchs M, Diehl V, Söhngen D (2001) Rituximab in the treatment of severe thrombotic thrombocytopenic purpura (ttp) (abstract 131). Blood 98
7. Chemnitz J, Schulz A, Diehl V, Söhngen D (2001) Thrombotisch-thrombozytopenische purpura (Moschcowitz-Syndrom). Med Klin 96:343-350
8. Fujikawa K, Suzuki H, McMullen B, Chung D (2001) Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98:1662-1666
9. Furlan M, Lämmle B (1999) Von Willebrand factor in thrombotic thrombozytopenic purpura. Thromb Haemost 82:592-600
10. Furlan M, Robles R, Lämmle B (1996) Partial purification and characterisation of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 10:4223-4234
11. Furlan M, Robles R, Solenthaler M, Lämmle B (1998) Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 91:2836-2846
12. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B (1998) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578-1584
13. Gerritsen HE, Robles R, Lämmle B, Furlan M (2001) Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 98:1654-1661
14. Gerritsen HE, Turecek PL, Schwarz HP, Lämmle B, Furlan M (1999) Assay of von Willebrand factor (vWF)-cleaving protease based in decreased collagen binding activity of degraded vWF. Thromb Haemost 82:1386-1389
15. Häberle J, Kehrel B, Ritter J, Jürgens H, Lämmle B, Furlan M (1999) New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: case report and review. Eur J Pediatr 158:883-887
16. He S, Cao H, Magnusson CGM, Eriksson-Berg M, Mehrkash M, Schenck-Gustafsson K, Blombäck M (2001) Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein. Thromb Res 103:241-248
17. Kasper CK (1991) Laboratory tests for factor VIII inhibitors, their variation, significance and interpretation. Blood Coagul Fibrinolysis 2:7-10
18. Knöbl P, Laczika K, Staudinger T, Haas M, Derfler K, Frass M, Schreiner J, Varadi K Turecek PL (2002) Kinetic of inhibitors of von Willebrand factor cleaving metalloprotease in three patients with severe thrombotic thrombocytopenic purpura (abstract 166). Ann Hematol 81 [Suppl]
19. Krizek DM, Rick ME (2001) Clinical application of a rapid method using agarose gel electrophoresis and Western blotting to evaluate von Willebrand factor protease activity. Electrophoresis 22:946-949
20. Lämmle B, Hunt BJ, Haycock GB, Furlan M (2002) Reply to rebuttal: von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome. Thromb Haemost 87:549-550
21. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD, Ginsburg D, Tsai HM (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488-494
22. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E (2001) Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 98:2730-2735
23. Mannucci PM, Galbusera M, Noris M, Canciani MT, Remuzzi G, Bianchi Bonomi A (2001) Deficiency of von Willebrand factor (vWF)-cleaving protease activity does not discriminate thrombotic thrombocytopenic purpura (TTP) from the hemolytic uremic syndrome (HUS) (abstract 3140). Blood 98
24. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D (1982) Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307:1432-1435
25. Moore JC, Hayward CPM, Warkentin TE, Kelton JG (2001) Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood 98:1842-1846
26. Moschcowitz E (1924) Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc 24:21-24
27. Obert B, Tout H, Veyradier A, Fressinaud E, Meyer D, Girma JP (1999) Estimation of the Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF. Thromb Haemost 82:1382-1385
28. Raife TJ, Atkinsons B, Christopherson P, Jozwiak M, Montgomery RR (2001) Recombinant, truncated monomeric von Willebrand factor (vWF) for the study of vWF proteolysis (abstract 1667). Thromb Haemost [SuppI July]
29. Tsai HM (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 10:4235-4244
30. Tsai HM (2000) High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura. Am J Hematol 65:251-255
31. Tsai HM, Li A, Rock G (2001) Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura. Clin Lab 47:387-392
32. Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic Purpura. N Engl J Med 339:1585-1594
33. Tsai HM, Rice L, Sarode R, Chow TW, Moake JL (2000) Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand Factor to platelets in Ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Intern Med 132:794-799
34. van der Plas RM, Schiphorst ME, Huizinga EG, Hene RJ, Verdonck LF, Sixma JJ, Fijnheer R (1999) Von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated thrombotic thrombocytopenic purpura. Blood 93:3798-3802
35. Veyradier A, Obert B, Houllier A, Meyer D, Girma JP (2001) Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 98:1765-1772